Home › Funds › APIS CAPITAL ADVISORS, LLC › PVLA

APIS CAPITAL ADVISORS, LLC position in PVLA

PALVELLA THERAPEUTICS INC NEW COM · Health Care

APIS CAPITAL ADVISORS, LLC reported holding 39,000 shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM) in its Q2 2026 13F filing — a position valued at US$6.0M, representing 0.58% of its reported portfolio and ranking #39 among its reported holdings. APIS CAPITAL ADVISORS, LLC has disclosed PVLA holdings in 3 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)39.00K sh
Reported value held$5.96M
Portfolio Weight0.58%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How APIS CAPITAL ADVISORS, LLC's PVLA position evolved

APIS CAPITAL ADVISORS, LLC first disclosed a stake in PVLA in Q3 2025 at 10,000 shares (US$627K). The position peaked in Q1 2026 at 89,000 shares, worth US$11.1M. Across 3 filings, APIS CAPITAL ADVISORS, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 39,000 shares valued at US$6.0M — a reduction of -50,000 shares quarter over quarter.. Notable position changes include a 56% trim in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 10.00K $626.90K New
Q1 2026 89.00K $11.09M New
Q2 2026 39.00K $5.96M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PVLA and 13F data

PVLA (PALVELLA THERAPEUTICS INC NEW COM) is a Health Care company. 90 other funds we track also report a position in PVLA — the largest reported positions include MONTANOVA CAPITAL, LLC (US$173.5M), Frazier Life Sciences Management, L.P. (US$134.8M), First Light Asset Management, LLC (US$118.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PVLA

All PVLA fund holders →

FAQ

How long has APIS CAPITAL ADVISORS, LLC held PVLA?

APIS CAPITAL ADVISORS, LLC has disclosed PVLA holdings in 3 of the last 4 reported quarters, going back to Q3 2025.

What is APIS CAPITAL ADVISORS, LLC's current position in PVLA?

As of Q2 2026, APIS CAPITAL ADVISORS, LLC holds 39.00K shares of PVLA (PALVELLA THERAPEUTICS INC NEW COM), valued at $5.96M, representing 0.58% of its reported portfolio and ranking #39.

Has APIS CAPITAL ADVISORS, LLC been buying or selling PVLA?

In the latest 13F filing (Q2 2026), APIS CAPITAL ADVISORS, LLC reduced its position in PVLA. The position peaked in Q1 2026 at 89.00K shares.

Which other funds hold PVLA?

Other major institutional holders of PVLA include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., First Light Asset Management, LLC, among 90 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.